Warmuth Markus
- SEC CIK
- 0001855643
In the past year, 7 open-market sale filings worth $951.1K and no purchases.
Current role at each company
- GLUE Monte Rosa Therapeutics, Inc.President & CEOas of Jul 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $951.1K
- 7 filings
- Net
- −$951.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Warmuth Markus as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 (view filing)4:05 PM ET | Jul 16 | 1 day | Warmuth MarkusPresident & CEO | SSale | −9.50K | $23.18 | −$220.2K | −1.6%585.0K after | |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Warmuth MarkusPresident & CEO | SSale | −5.47K | $19.44 | −$106.2K | −0.9%594.5K after | 2 lots10b5-1 |
| May 5, 2026 (view filing) | May 1 | 4 days | Warmuth MarkusPresident & CEO | SSale | −5.47K | $18.92 | −$103.4K | −0.9%600.0K after | 10b5-1 |
| Apr 15, 2026 (view filing) | Apr 14 | 1 day | Warmuth MarkusPresident & CEO | SSale | −8.00K | $17.64 | −$141.1K | −1.3%605.5K after | |
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Warmuth MarkusPresident & CEO | SSale | −5.47K | $17.92 | −$98.0K | −0.9%613.5K after | 10b5-1 |
| Jan 9, 2026 (view filing) | Jan 7 | 2 days | Warmuth MarkusPresident & CEO | SSale | −5.47K | $23.48 | −$128.4K | −0.9%618.9K after | 3 lots10b5-1 |
| Jan 5, 2026 (view filing) | Jan 5 | Same day | Warmuth MarkusPresident & CEO | SSale | −10.1K | $15.17 | −$153.7K | −1.6%624.4K after |